JHS Svendgaard Laboratories Limited Stock Price Today (NSE: JHS)
Fundamental Score
JHS Svendgaard Laboratories Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
JHS Svendgaard Laboratories Limited share price today is ₹8.51, down 3.19% on NSE/BSE as of 16 September 2026. JHS Svendgaard Laboratories Limited (JHS) is a Small-cap company in the Personal Care sector with a market capitalisation of ₹74.38 (Cr). The 52-week high for JHS share price is ₹13.90 and the 52-week low is ₹6.26. The company has a Return on Equity (ROE) of -1.11% and a debt-to-equity ratio of 0.08.
JHS Svendgaard Laboratories Limited Share Price Chart — NSE/BSE Historical Performance
JHS Svendgaard Laboratories Limited share price chart: 2.40% return over the past month. 52-week high ₹13.90, 52-week low ₹6.26.
JHS Svendgaard Laboratories Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹8.99 | ₹8.99 | ₹8.29 | ₹8.51 | 1.32L (Cr) | |
| ₹8.45 | ₹9.39 | ₹8.45 | ₹8.79 | 3.77L (Cr) | |
| ₹8.38 | ₹9.21 | ₹7.91 | ₹8.43 | 3.06L (Cr) | |
| ₹7.91 | ₹8.35 | ₹7.90 | ₹8.03 | 36.29K (Cr) | |
| ₹8.25 | ₹8.40 | ₹7.66 | ₹8.11 | 47.34K (Cr) | |
| ₹7.99 | ₹8.31 | ₹7.85 | ₹7.97 | 23.84K (Cr) | |
| ₹7.89 | ₹8.15 | ₹7.85 | ₹7.99 | 22.92K (Cr) | |
| ₹7.86 | ₹8.08 | ₹7.81 | ₹7.89 | 45.83K (Cr) | |
| ₹7.81 | ₹8.04 | ₹7.81 | ₹7.86 | 37.42K (Cr) | |
| ₹8.29 | ₹8.29 | ₹7.77 | ₹7.81 | 52.59K (Cr) |
JHS Svendgaard Laboratories Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹8.42 | ₹9.39 | ₹7.66 | ₹8.51 | +1.07% | |
| ₹7.74 | ₹9.41 | ₹7.49 | ₹8.06 | +4.13% | |
| ₹7.70 | ₹8.16 | ₹7.00 | ₹7.57 | -1.69% | |
| ₹9.03 | ₹9.44 | ₹7.40 | ₹7.46 | -17.39% | |
| ₹9.15 | ₹9.53 | ₹8.25 | ₹9.03 | -1.31% | |
| ₹6.81 | ₹9.77 | ₹6.78 | ₹8.85 | +29.96% | |
| ₹9.02 | ₹9.99 | ₹6.26 | ₹6.55 | -27.38% | |
| ₹10.50 | ₹12.00 | ₹9.00 | ₹9.50 | -9.52% | |
| ₹9.99 | ₹12.90 | ₹8.66 | ₹10.48 | +4.90% | |
| ₹10.89 | ₹11.78 | ₹9.25 | ₹9.82 | -9.83% | |
| ₹13.26 | ₹13.40 | ₹10.18 | ₹10.72 | -19.16% | |
| ₹10.71 | ₹13.90 | ₹10.71 | ₹13.00 | +21.38% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
JHS Svendgaard Laboratories Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
JHS Svendgaard Laboratories Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JHS across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Revenue Growth (29.53%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 2.18)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-1.11%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-0.80%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-1.34%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Limited Growth History (0.18% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-1.67x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-78.21 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.60%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
JHS Svendgaard Laboratories Limited vs Personal Care Peers
Peer Comparison - Personal Care
Compare JHS Svendgaard Laboratories Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
12/100 | ₹8.51₹9 | ₹74.38₹74.38 | — — | -1.11%Poor -1.11% Poor | -0.80%Poor -0.80% Poor | 0.08Excellent 0.1 Excellent | — — | 0.18%Average 0.18% Average | 0.00% | |
Godrej Consumer Products LimitedGodrej Consumer... GODREJCP • 532424 | 51.3/100 | ₹863.80₹864 | ₹88384.02₹88384.02 | 46.17Average 46.2 Average | 15.10%Good 15.10% Good | 22.16%Excellent 22.16% Excellent | 0.33Excellent 0.3 Excellent | 1.58%Average 1.58% Average | 6.60%Good 6.60% Good | 1.90% |
Dabur India LimitedDabur India Lim... DABUR • 500096 | 48.2/100 | ₹371.55₹372 | ₹65912.97₹65912.97 | 33.41Average 33.4 Average | 17.06%Good 17.06% Good | 21.26%Excellent 21.26% Excellent | 0.09Excellent 0.1 Excellent | 2.28%Average 2.28% Average | 6.65%Good 6.65% Good | 1.91% |
Colgate Palmolive (India) LimitedColgate Palmoli... COLPAL • 500830 | 52.6/100 | ₹1800.00₹1800 | ₹48960.00₹48960.00 | 36.33Average 36.3 Average | 81.59%Excellent 81.59% Excellent | 104.96%Excellent 104.96% Excellent | 0.00Excellent 0.0 Excellent | 5.06%Good 5.06% Good | 4.51%Average 4.51% Average | 2.54% |
Cupid LimitedCupid Limited... CUPID • 530843 | 62.9/100 | ₹279.70₹280 | ₹37610.17₹37610.17 | 102.83Average 102.8 Average | 27.30%Excellent 27.30% Excellent | 35.38%Excellent 35.38% Excellent | 0.11Excellent 0.1 Excellent | 30.15%Excellent 30.15% Excellent | 20.00%Excellent 20.00% Excellent | 0.00% |
55.6/100 | ₹7615.00₹7615 | ₹24718.29₹24718.29 | 31.26Average 31.3 Average | 114.93%Excellent 114.93% Excellent | 136.60%Excellent 136.60% Excellent | 0.00Excellent 0.0 Excellent | 14.51%Good 14.51% Good | 7.40%Good 7.40% Good | 2.61% | |
Gillette India LimitedGillette India ... GILLETTE • 507815 | 70.7/100 | ₹7479.50₹7480 | ₹24375.69₹24375.69 | 36.48Average 36.5 Average | 66.44%Excellent 66.44% Excellent | 81.46%Excellent 81.46% Excellent | 0.00Excellent 0.0 Excellent | 23.18%Excellent 23.18% Excellent | 13.04%Good 13.04% Good | 2.30% |
Emami LimitedEmami Limited... EMAMILTD • 531162 | 41.7/100 | ₹369.10₹369 | ₹16111.22₹16111.22 | 21.52Average 21.5 Average | 27.60%Excellent 27.60% Excellent | 29.94%Excellent 29.94% Excellent | 0.04Excellent 0.0 Excellent | 11.26%Good 11.26% Good | 5.58%Good 5.58% Good | 2.43% |
Honasa Consumer LimitedHonasa Consumer... HONASA • 544014 | 59.7/100 | ₹471.05₹471 | ₹15317.79₹15317.79 | 61.58Average 61.6 Average | 15.43%Good 15.43% Good | 19.16%Good 19.16% Good | 0.00Excellent 0.0 Excellent | 16.57%Excellent 16.57% Excellent | 39.06%Excellent 39.06% Excellent | 0.00% |
Bajaj Consumer Care LimitedBajaj Consumer ... BAJAJCON • 533229 | 62.3/100 | ₹521.45₹521 | ₹6811.08₹6811.08 | 31.22Average 31.2 Average | 0.00%Poor 0.00% Poor | 30.53%Excellent 30.53% Excellent | 0.00Excellent 0.0 Excellent | -3.53%Poor -3.53% Poor | 4.79%Average 4.79% Average | 0.00% |
Anondita MediAnondita Medi... ANONDITA • | 44.6/100 | ₹1144.35₹1144 | ₹2139.01₹2139.01 | 63.95Average 64.0 Average | 40.03%Excellent 40.03% Excellent | 43.60%Excellent 43.60% Excellent | 0.26Excellent 0.3 Excellent | — — | — — | 0.00% |
Top Personal Care Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Godrej Consumer Products Limited share price88384.02 Cr
- Dabur India Limited share price65912.97 Cr
- Colgate Palmolive (India) Limited share price48960.00 Cr
- Cupid Limited share price37610.17 Cr
- Procter & Gamble Hygiene and Health Care Limited share price24718.29 Cr
JHS Svendgaard Laboratories Limited Quarterly Performance
Latest quarterly metrics for JHS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
29.53%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
3.34%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
0.18%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
JHS Svendgaard Laboratories Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for JHS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
JHS Svendgaard Laboratories Limited Financial Statements
Annual income statement, balance sheet and cash flow for JHS Svendgaard Laboratories Limited (JHS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for JHS Svendgaard Laboratories Limited
About JHS (JHS Svendgaard Laboratories Limited)
JHS Svendgaard Laboratories Ltd is a prominent player in the Indian personal care market, specializing in the creation and distribution of a diverse portfolio of oral and dental hy...giene essentials. With a strong focus on innovation and quality, JHS crafts a comprehensive range of products designed to cater to the everyday needs of consumers. Their offerings span from essential toothbrushes and invigorating toothpastes to refreshing mouthwashes, ensuring a complete oral care routine. The company's commitment extends beyond basic hygiene, venturing into specialized products like teeth whitening gels and denture care tablets, showcasing their dedication to addressing specific consumer demands within the oral health sector. Beyond oral care, JHS Svendgaard Laboratories demonstrates its adaptability by extending its expertise to other personal care segments. The company manufactures and markets a range of products including gentle talcum powders, hand sanitizers, and versatile detergents, reflecting a holistic approach to hygiene and well-being. This diversification allows JHS to reach a broader consumer base and establish a stronger foothold in the competitive personal care market. By consistently innovating and expanding its product lines, JHS Svendgaard Laboratories aims to become a trusted household name, synonymous with quality and reliability in personal care solutions. Moreover, JHS Svendgaard Laboratories actively participates in the global market through its export operations, further solidifying its presence and reach. The company's commitment to maintaining international standards of quality and manufacturing allows it to successfully compete in diverse markets. In addition to its own branded products, JHS also offers contract manufacturing services for oral care products, leveraging its state-of-the-art facilities and expertise to support other brands in the industry. This dual approach, combining proprietary products with contract manufacturing, positions JHS Svendgaard Laboratories as a versatile and reliable partner in the personal care sector, driving growth and innovation across the industry.
Company Details
Key Leadership
JHS Share Price: Frequently Asked Questions
What is the current share price of JHS Svendgaard Laboratories Limited?
JHS Svendgaard Laboratories Limited (JHS) trades at ₹8.51 on NSE and BSE. Market cap ₹74.38 (Cr). Educational data only.
What is the P/E ratio of JHS Svendgaard Laboratories Limited?
JHS Svendgaard Laboratories Limited has a P/E of N/Ax vs industry average 40.63x.
What is the Bull Run score for JHS Svendgaard Laboratories Limited?
JHS Svendgaard Laboratories Limited has a Bull Run score of 12/100 based on 25+ financial parameters.
Does JHS Svendgaard Laboratories Limited pay dividends?
JHS Svendgaard Laboratories Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of JHS Svendgaard Laboratories Limited?
JHS Svendgaard Laboratories Limited has ROE of -1.11%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of JHS Svendgaard Laboratories Limited?
JHS Svendgaard Laboratories Limited has debt-to-equity of 0.08.
Is JHS Svendgaard Laboratories Limited a good investment?
Bull Run gives JHS Svendgaard Laboratories Limited a score of 12/100. This is not investment advice — consult a SEBI-registered advisor.